Area of research
Molecular Medicine · Pharmacology
Research interest
Research interests include Biology, Virology, Chemistry, Bacteria, Computational biology, and Pseudomonas aeruginosa.
Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections
microbeMASST: a taxonomically informed mass spectrometry search tool for microbial metabolomics data
A Taxonomically-informed Mass Spectrometry Search Tool for Microbial Metabolomics Data
Moonlighting chaperone activity of the enzyme PqsE contributes to RhlR-controlled virulence of Pseudomonas aeruginosa
Trojan Horse Siderophore Conjugates Induce <i>Pseudomonas aeruginosa</i> Suicide and Qualify the TonB Protein as a Novel Antibiotic Target
Towards the sustainable discovery and development of new antibiotics
Higher Trimethylamine- <i>N</i> -Oxide Plasma Levels with Increasing Age Are Mediated by Diet and Trimethylamine-Forming Bacteria
Optimization of Artificial Siderophores as <sup>68</sup>Ga-Complexed PET Tracers for In Vivo Imaging of Bacterial Infections
A simplified LC-MS/MS method for the quantification of the cardiovascular disease biomarker trimethylamine-N-oxide and its precursors
Elucidation of the life cycle of the endophytic genus Muscodor and its transfer to Induratia in Induratiaceae fam. nov., based on a polyphasic taxonomic approach
Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry
Targeting cellular fatty acid synthesis limits T helper and innate lymphoid cell function during intestinal inflammation and infection
Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia
Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated Virolysis
Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation
Editorial: Are natural products the solution to antimicrobial resistance?
Drug Innovation in Academia: A Helmholtz Drug Research Initiative Conference
Targeting DnaN for tuberculosis therapy using novel griselimycins
The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad Anti-HIV and Anti-HSV Activity with Potential for Microbicidal Applications